CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 146 filers reported holding CEMPRA INC in Q2 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $28,000 | +75.0% | 1,157 | +22.4% | 0.00% | – |
Q2 2016 | $16,000 | -61.0% | 945 | -20.9% | 0.00% | -100.0% |
Q1 2016 | $41,000 | +310.0% | 1,194 | +280.3% | 0.00% | – |
Q4 2015 | $10,000 | -16.7% | 314 | -24.5% | 0.00% | – |
Q3 2015 | $12,000 | -71.4% | 416 | -65.6% | 0.00% | -100.0% |
Q2 2015 | $42,000 | +2.4% | 1,210 | +1.3% | 0.00% | 0.0% |
Q1 2015 | $41,000 | +115.8% | 1,194 | +49.4% | 0.00% | – |
Q4 2014 | $19,000 | – | 799 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |